No Data
No Data
Could The Market Be Wrong About Vitura Health Limited (ASX:VIT) Given Its Attractive Financial Prospects?
Vitura Health Resets Business Strategy
Vitura Health (ASX:VIT) on Wednesday launched its business strategy reset following a strategic review conducted by recently appointed Chairman Robert Iervasi, according to a same-day filing with the
Vitura Health's Shares Jump 19% After Securing Injunction Order Over Code4 Spat
Vitura Health's (ASX:VIT) shares jumped 19% on Friday after its subsidiary, Canview, secured an injunction order restraining Code4 Cannabis from terminating their services agreement. The Supreme Court
Vitura Health's Services Agreement With Code4 at Risk of Termination; Shares Plunge 31%
Vitura Health (ASX:VIT) is taking Code4 Cannabis to court amid a looming termination of an agreement between the two companies, sending the ASX-listed company's shares down more than 30% at Tuesday's
Vitura Health CEO to Step Down by June-End
Rodney Cocks will step down as CEO and executive director of digital health platform Vitura Health (ASX:VIT), effective June 30, according to a Monday filing with the Australian Securities Exchange. T
Vitura Health JV Commences Manufacture of GMP LaNeo MDMA; Shares Up 3%
Vitura Health (ASX:VIT), through its joint venture, Cortexa, commenced manufacturing of GMP LaNeo MDMA 40mg capsules to support both clinical trials and use under the Therapeutic Goods Administration'
No Data